Your browser doesn't support javascript.
loading
A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma.
Hall, Peter E; Lewis, Rachel; Syed, Nelofer; Shaffer, Richard; Evanson, Jane; Ellis, Stephen; Williams, Matthew; Feng, Xiaoxing; Johnston, Amanda; Thomson, Jim A; Harris, Fiona P; Jena, Raj; Matys, Tomasz; Jefferies, Sarah; Smith, Kate; Wu, Bor-Wen; Bomalaski, John S; Crook, Timothy; O'Neill, Kevin; Paraskevopoulos, Dimitris; Khadeir, Ramsay S; Sheaff, Michael; Pacey, Simon; Plowman, Piers N; Szlosarek, Peter W.
Afiliação
  • Hall PE; Department of Oncology, Barts Health NHS Trust, London, United Kingdom.
  • Lewis R; Department of Oncology, Barts Health NHS Trust, London, United Kingdom.
  • Syed N; Department of Medicine, Imperial College, London, United Kingdom.
  • Shaffer R; St. Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, United Kingdom.
  • Evanson J; Department of Radiology, Barts Health NHS Trust, London, United Kingdom.
  • Ellis S; Department of Radiology, Barts Health NHS Trust, London, United Kingdom.
  • Williams M; Department of Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Feng X; Polaris Pharmaceuticals Inc., San Diego, California.
  • Johnston A; Polaris Pharmaceuticals Inc., San Diego, California.
  • Thomson JA; Polaris Pharmaceuticals Inc., San Diego, California.
  • Harris FP; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Jena R; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
  • Matys T; Department of Radiology, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Jefferies S; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Smith K; Department of Oncology, Barts Health NHS Trust, London, United Kingdom.
  • Wu BW; Polaris Pharmaceuticals Inc., San Diego, California.
  • Bomalaski JS; Polaris Pharmaceuticals Inc., San Diego, California.
  • Crook T; St. Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, United Kingdom.
  • O'Neill K; Department of Neurosurgery, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Paraskevopoulos D; Department of Neurosurgery, Barts Health NHS Trust, London, United Kingdom.
  • Khadeir RS; Centre for Molecular Oncology, Queen Mary University of London, London, United Kingdom.
  • Sheaff M; Department of Pathology, Barts Health NHS Trust, London, United Kingdom.
  • Pacey S; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
  • Plowman PN; Department of Oncology, Barts Health NHS Trust, London, United Kingdom.
  • Szlosarek PW; Department of Oncology, Barts Health NHS Trust, London, United Kingdom. p.w.szlosarek@qmul.ac.uk.
Clin Cancer Res ; 25(9): 2708-2716, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30796035
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arginina / Argininossuccinato Sintase / Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioma / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arginina / Argininossuccinato Sintase / Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioma / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article